IFNAR1 and infection: A dose of 1 mg per mouse of anti-IFNAR1 mAb, followed by a viral dose of 104TCID50, elicited death in 83% and 67%, and a symptomatic disease in 100% and 83% of mice when the mAb was administered 48 h or 24 h before infection respectively.